Clinical trial
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
NCT00001254 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00001254 |
|---|---|
| Title | Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome |
| Official title | Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Zollinger Ellison Syndrome |
| Enrollment | 273 |
| Start date | Oct 29, 1991 |
| First posted | Nov 4, 1999 |
| Last update posted | Jan 8, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: